Lisdexamfetamine for methamphetamine withdrawal (OLAM trial)
Oral Lisdexamfetamine for the treatment of Acute Methamphetamine withdrawal (the OLAM trial): A randomised controlled trial
Naltrexone-Bupropion for Methamphetamine Use Disorder (NABU)
An Open-Label Safety and Feasibility Pilot Trial of Oral Naltrexone-Bupropion Combination Pharmacotherapy for Methamphetamine Use Disorder
Ketamine-assisted psychotherapy for methamphetamine use disorder (KAPPA)
An open-label, safety and feasibility pilot study of ketamine-assisted psychotherapy for methamphetamine use disorder
Friday 22nd November
2024 NCCRED Symposium
The 2024 NCCRED Symposium discussed innovations within the alcohol and other drug sector which aim to improve the health outcomes for people who use methamphetamine and emerging drugs of concern.